Tag: <span>Amy Yang</span>

Asia & Pacific Legal Chronicle. December 15, 2021

China National Biotech Group’s Joint Venture with Innova Medical Group

By Sonia Carcano

Bird & Bird has successfully advised China National Biotech Group on its investment to establish the joint venture company with Innova Medical Group in Singapore, to […]

Meta Platforms’ $10 Billion Senior Unsecured Notes Offering

Whirlpool Corporation’s $3 Billion Acquisition of InSinkErator

Gallatin Point Capital’s $100 Million Equity Investment in Insurance Supermarket International

Unico’s R$150 Million Acquisition of MakroSystems

CRM&Bonus’ R$25 Million Acquisition of Zipper

Spathiphy Capital’s $60 Million Launch of Spathiphy Ace Fund and Spathiphy Ace Feeder Fund

Széchenyi Funds’ Investment in Flashpoint

Colas Rail’s Acquisition of Hasselmann Group

European Logistics Investment’s Transactions on Polish Logistics Market

Intro Power & Utilities’ 14 MW Co-generation Project Agreement with NCMP

GlaxoSmithKline Services Unlimited’s Separation from Haleon

Telecom Egypt’s Commercial Agreements with Orange Egypt

Phoenix and More v. Megureit Israel

Masdar’s USD 114.2 Million Project Financing in Azerbaijan

Tabby’s USD150 Million Debt Financing

Route Mobile Limited’s Buyback of Equity Shares

Qapita Fintech India’s Acquisition of KP Corporate Solutions

Saha Pathana Inter-Holding Public Company’s Acquisition of Shares of Thanulux

Norton Rose Fulbright expands innovation and tech capabilities in Germany

Norton Rose Fulbright appoints Yianni Cheilas as head of Greece

Womble Bond Dickinson Enters San Francisco Legal Market, Combines with Cooper, White & Cooper

From SMP to YPOG: Business law firm with new name and expanded partner base

Federico Michele Sorrentino is the new Avocom’s Equity Partner

Partner Todd Angkatavanich Joins McDermott in New York

K&L Gates adds Antitrust, Competition, and Trade Regulation Partner in Washington, D.C.

Johnson Winter & Slattery to open in Canberra and broaden its foreign investment/M&A team

Amy Yang

China National Biotech Group’s Joint Venture with Innova Medical Group